Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study

Roger S. McIntyre,Rita Prieto,Patricia Schepman,Yu-Chen Yeh,Matthieu Boucher,A. Shelbaya,Richard Chambers,Xin Gao,Elizabeth Pappadopulos

Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study

2019

Roger S. McIntyre
Rita Prieto
Patricia Schepman
Yu-Chen Yeh
Matthieu Boucher
A. Shelbaya
Richard Chambers
Xin Gao
Elizabeth Pappadopulos

AbstractBACKGROUND: Guidelines recommend selective serotonin reuptake inhibitors (SSRI) and serotonin norepinephrine reuptake inhibitors (SNRI) as first-line treatments for major depressive disorde...

Keywords:

Norepinephrine reuptake
Anesthesia
Serotonin
Intensive care medicine
Health care
Major depressive disorder
Diabetes mellitus
Medicine
Reuptake inhibitor
pharmacological treatment
serotonin reuptake
resource use

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations